Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
Top
..
c19early.org COVID-19 treatment researchSelect treatment..Select..
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

Daptomycin for COVID-19

Daptomycin has been reported as potentially beneficial for COVID-19 in the following study. We have not reviewed daptomycin in detail.
COVID-19 involves the interplay of over 200 viral and host proteins and factors providing many therapeutic targets. Scientists have proposed over 10,000 potential treatments. c19early.org analyzes 170+ treatments.
Sisti et al., Evaluation of respiratory virus transmissibility and resilience from fomites: the case of 11 SARS-CoV-2 clinical isolates, Applied and Environmental Microbiology, doi:10.1128/aem.00774-25
ABSTRACT The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic, significantly impacting social and economic aspects of society. While belonging to the Coronaviridae family, SARS-CoV-2 exhibited unique characteristics that facilitated its widespread transmission and pathogenicity. This study aimed to investigate the molecular characterization and infection kinetics of emerging SARS-CoV-2 variants, focusing on four key virological aspects: viral entry mechanisms, replication dynamics, immune evasion strategies, and surface persistence. We isolated 11 SARS-CoV-2 variants from clinical samples and conducted in vitro studies using Calu-3 cell lines and pseudovirus systems to explore viral entry. Whole-genome sequencing identified mutations linked to increased replication and enhanced immune evasion, particularly through the inhibition of interferon responses. Additionally, persistence studies on common environmental surfaces (copper, aluminum, and plastic) revealed that certain variants, such as G446S, contributed to increased viral stability, suggesting potential for indirect transmission beyond direct person-to-person contact. Furthermore, we evaluated the effectiveness of “green” disinfectants, including tea tree oil and quercetin-based compounds, which demonstrated viral load reductions of over 95% within minutes, outperforming conventional alcohol- and UV-based disinfection methods. Notably, two influenza virus isolates belonging to highly divergent subtypes are sanitized as well while showing different persistence surface profiles compared to SARS-CoV-2. These findings highlight the evolutionary strategies employed by SARS-CoV-2 to ensure transmission, its ability to adapt under selective pressure, and the importance of ongoing surveillance of emerging variants. Moreover, the efficacy of environmentally sustainable disinfectants presents a promising strategy for reducing viral transmission in both clinical and community settings. IMPORTANCE In this study, we evaluated the molecular profile of 11 SARS-CoV-2 variants, focusing on four key virological aspects: viral entry mechanisms, replication dynamics, immune evasion strategies, and surface persistence. Through whole-genome sequencing, we identified mutations linked to enhanced replication and immune evasion, notably through the suppression of interferon responses. Additionally, persistence studies on common environmental surfaces (copper, aluminum, and plastic) demonstrated that certain mutations, such as G446S, exhibited increased stability, suggesting a potential role for indirect transmission. This study underscores the need for continuous monitoring and the potential of eco-friendly disinfection approaches in controlling the spread of SARS-CoV-2 and possibly of other respiratory..
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.
Submit